Pharmaceutical - Women's Health, Licensing


Current filters:

Women's HealthLicensing

Popular Filters

Dilafor partners with Lee’s Pharmaceutical for tafoxiparin


Sweden-based Dilafor AB, a Karolinska Development portfolio company, and Lee’s Pharmaceutical Holdings,…

Asia-PacificChinaDilafor ABKarolinska DevelopmentLee's PharmaceuticalLicensingPharmaceuticalReproductivetafoxiparinWomen's Health

Advaxis out-licenses ADXS-HPV to Biocon for emerging markets

Advaxis out-licenses ADXS-HPV to Biocon for emerging markets


Indian biotech firm Biocon has entered into an exclusive licensing agreement for US cancer drug developer…

AdvaxisADXS-HPVAsia-PacificBioconIndiaLicensingOncologyPharmaceuticalWomen's Health

Retrophin to acquire Kyalin Biosciences; in-licenses Syntocinon


In a second takeover bid within a matter of months, USA-based Retrophin announced that it will acquire…

Kyalin BiosciencesLicensingMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalRetrophinSyntocinonWomen's Health

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market

Ablynx and Eddingpharm sign deal to target Chinese osteoporosis market


Ablynx has granted an exclusive license to Eddingpharm to develop and commercialize its anti-RANKL Nanobody,…

AblynxAsia-PacificEddingpharmLicensingPharmaceuticalWomen's Health

Phebra gains right to market Syntometrine in Australia

Phebra gains right to market Syntometrine in Australia


Phebra has signed an exclusive commercial agreement with UK-based pharmaceutical firm Alliance Pharma…

Alliance PharmaAsia-PacificLicensingPharmaceuticalSyntometrineWomen's Health

Pharmaceutical patent sale of first-in-class compounds to treat women's health needs


IP Shakti, an early-stage seed fund for biomedical and life science innovations and the exclusive broker…

BezielleIP ShaktiLicensingMenerbaPatentsPharmaceuticalSealaWomen's Health

ObsEva gets funding and makes deal with Merck Serono


Geneva, Switzerland-based ObsEva says that it has closed a 32 million Swiss franc ($34.8 million) -A…

FinancialLicensingMerck KGaAMerck SeronoObsEvaPharmaceuticalWomen's Health

Actavis gains global rights for antifungal agent albaconazole


US generic drugs major Actavis (NYSE: ACT),which also has strong interests in women's health products,…

ActavisalbaconazoleGlobalLicensingPalau PharmaPharmaceuticalWomen's Health

BMG Pharma and Julphar in women's health licensing deal


Italian specialty drugmaker BMG Pharma and United Arab Emirates-based Julphar - Gulf Pharmaceutical Industries…

BMG GinoxilBMG PharmaJulpharLicensingPharmaceuticalRest of the WorldWomen's Health

Ligand enters global license deal for women's health product


Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

Sinclair IS in Flammacerium deal with Hikma; sells Fazol G to Majorelle


UK specialty pharma firm Sinclair IS Pharma (AIM: SPH.L) and Jordon-headquartered Hikma Pharmaceuticals…

Antibiotics and Infectious diseasesFazol GHikma PharmaceuticalsLaboratoires MajorelleLicensingPharmaceuticalSinclair IS PharmaWomen's Health

Bayer inks up to 592 million-euro endometriosis deal with Evotec


Drug major Bayer (BAYN: DE) and fellow German company Evotec (EVT: TecDAX) have entered into a five-year,…

BayerEvotecLicensingPharmaceuticalWomen's Health

BioSante Pill-Plus improves sexual desire, arousal


US drug developer BioSante Pharmaceuticals (Nasdaq: BPAX) says that data from studies of the Pill-Plus…

BioSante PharmaceuticalsLicensingPantarhei BiosciencePharmaceuticalPill-PlusReproductiveResearchWomen's Health

Columbia Labs hands over NDA to Watson


Columbia Laboratories (Nasdaq: CBRX) has transferred the New Drug Application for progesterone vaginal…

Columbia LaboratoriesCrinoneLicensingNorth AmericaPharmaceuticalRegulationReproductiveWatson PharmaceuticalsWomen's Health

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top